Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
about
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Molecular Pathogenesis of NASHGut Microbiota and Host Reaction in Liver DiseasesGut microbiota and host metabolism in liver cirrhosisAcute-on-chronic Liver Failure.2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 MiceBacterial translocation aggravates CCl4-induced liver cirrhosis by regulating CD4+ T cells in ratsStarring role of toll-like receptor-4 activation in the gut-liver axis.Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.Acute-on-chronic liver failure: terminology, mechanisms and management.Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.Low-grade endotoxemia and platelet activation in cirrhosis.Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.Bacteriophages as potential new mammalian pathogens.Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver.Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats.Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?Changes of Intestinal Functions in Liver Cirrhosis.Rifaximin has the potential to prevent complications of cirrhosisPortal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
P2860
Q26778032-7B6BDF53-60E1-420E-94AF-30D44B372B44Q28071265-8763EC37-85D0-4B53-AB01-D827B555F3C7Q28083295-1E5D87ED-68CB-420B-89B2-04534BD4140FQ28085155-3AC9921F-B25C-40EF-8F12-2E2B412C3C2DQ34542736-C5AA27DB-384C-42A2-A3C1-1378F6742971Q37228134-7314542C-E37F-432A-A9EE-7913290975B8Q37612290-55D4140F-BCD9-411F-8D79-4FCEEC1B5044Q38645789-06292CFF-5475-45BA-BC33-4BD643957058Q38708565-C0AF483E-DEC8-44B0-BC15-13A37380D6E6Q38720387-C21A82ED-C600-429F-9E62-2ABC118896A0Q38750137-287734C1-E3C8-4905-8155-19456AC50FFFQ40536260-5FA32DBC-3040-46F3-A8E6-888DFA357F19Q40552238-2DA3D2B4-7A45-4408-AEB1-4E63F96333FFQ41203961-55657AAB-725A-4D78-B228-6B5D9FC80B2EQ41706834-07390D30-D5FA-4368-90DC-77F76B697FDEQ42042373-B07D038A-B011-4964-B169-94E47828394CQ42356646-6C45D812-1C25-4E97-A104-BE754547B2C6Q42682576-E4724A46-1ACB-4165-B2C6-9A7B2CF6204AQ45399180-0CF7E207-38F2-4B4A-B504-8BF42934AB7FQ47106081-2CF926FB-36C1-433B-8B0D-A25768A9DAF8Q47118655-1F70D8A8-29F1-4D7B-9014-44A4F054BD02Q50048814-90024531-36A9-4143-BD81-47D60F31BCFDQ50099829-21792BB7-B31B-445F-A148-C4998282E963Q52312388-BAA886D1-9F12-40CB-BA73-DA16C84CECA4Q55252106-3F1A28F3-F917-4808-B231-AE3E3E7ACDEDQ55322856-7A2E3493-CDF0-46AB-9BB0-A3A8BB87CC3BQ57067778-F59BEF93-52EB-42D1-97F4-F8645F79D46EQ57807139-E995FD23-1F55-4D6C-8347-45990478C721
P2860
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@ast
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@en
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@nl
type
label
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@ast
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@en
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@nl
prefLabel
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@ast
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@en
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@nl
P2860
P3181
P356
P1476
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
@en
P2093
Hiroshi Fukui
P2860
P304
P3181
P356
10.4254/WJH.V7.I3.425
P407
P577
2015-03-27T00:00:00Z